The Ceftizoxime Sodium, cataloged under National Stock Number 6505-01-350-0359, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Astellas Pharma Us, Inc.. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-350-0359 |
| Primary Part Number | NDC00469-7252-01 |
| Item Name | Ceftizoxime Sodium |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Astellas Pharma Us, Inc. |
| Status | ACTIVE |
| Primary Container Content Quantity | 100.000 MILLILITERS AFTER RECONSTITUTION |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL |
| Physical Form | POWDER |
| Total Primary Container Quantity | 10 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00469-7252-01 PRIMARY | Astellas Pharma Us, Inc. (USA) |
| NDC00469-7252-01 | Cardinal Health 200, Llc (USA) |
| Reference | Meaning |
|---|---|
| NDC57317-0252-01 | 5/9 Secondary reference Astellas Pharma Us, Inc. |
| CEFIZOX | 5/1 Secondary reference Astellas Pharma Us, Inc. |
NSN 6505-01-350-0359 is a Ceftizoxime Sodium, manufactured by Astellas Pharma Us, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-350-0359 has 2 manufacturer part numbers on file: NDC00469-7252-01 (Astellas Pharma Us, Inc.), NDC00469-7252-01 (Cardinal Health 200, Llc).
Key specifications for NDC00469-7252-01: Primary Container Content Quantity: 100.000 MILLILITERS AFTER RECONSTITUTION; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL; Physical Form: POWDER. 5 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.